AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 21.58

Change

-0.21 (-0.96)%

Market Cap

USD 14.69B

Volume

7.04M

Analyst Target

USD 23.81
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania. Address: Radnor Corporate Center, Radnor, PA, United States, 19087

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-0.05 (-0.02%)

USD 66.85B
ALC Alcon AG

+0.60 (+0.69%)

USD 43.35B
RMD ResMed Inc

-11.77 (-4.76%)

USD 35.86B
BAX Baxter International Inc

-1.20 (-3.55%)

USD 17.26B
ATR AptarGroup Inc

-0.20 (-0.11%)

USD 11.68B
TFX Teleflex Incorporated

-1.60 (-0.82%)

USD 9.08B
BLCO Bausch + Lomb Corp

+0.22 (+1.13%)

USD 6.88B
STVN Stevanato Group SpA

-0.19 (-0.92%)

USD 5.19B
WRBY Warby Parker Inc

-0.11 (-0.52%)

USD 2.03B
INFU InfuSystems Holdings Inc

-0.58 (-6.10%)

USD 0.17B

ETFs Containing AVTR

COPP Sprott Copper Miners ETF 10.10 % 0.00 %

-0.47 (0%)

N/A
CEBS:XETRA iShares Copper Miners UCI.. 5.75 % 0.00 %

-0.01 (0%)

USD 0.05B
GMTL:AU Global X Green Metal Mine.. 4.94 % 0.00 %

-0.28 (0%)

N/A
XMET:AU BetaShares Energy Transit.. 4.93 % 0.00 %

-0.07 (0%)

N/A
COPX Global X Copper Miners ET.. 4.79 % 0.65 %

-1.06 (0%)

USD 2.59B
COPG:LSE Global X Copper Miners UC.. 4.65 % 0.00 %

-0.21 (0%)

USD 0.17B
COPX:SW Global X Copper Miners UC.. 4.56 % 0.00 %

-0.27 (0%)

N/A
D6AT:XETRA Global X Disruptive Mater.. 4.46 % 0.00 %

+0.05 (+0%)

N/A
COPX:LSE Global X Copper Miners UC.. 4.31 % 0.00 %

-0.38 (0%)

N/A
COPA 3.80 % 0.00 %

N/A

N/A
M7ES:XETRA HANetf ICAV - Sprott Ener.. 3.68 % 0.00 %

+0.03 (+0%)

USD 4.70M
EXV6:XETRA iShares STOXX Europe 600 .. 3.57 % 0.00 %

+0.17 (+0%)

USD 0.37B
EMOM:PA BNP Paribas Easy ESG Equi.. 2.26 % 0.00 %

+0.36 (+0%)

USD 3.00M
MOED:PA BNP Paribas Easy - Equity.. 2.26 % 0.00 %

+0.26 (+0%)

USD 0.79M
MOED:XETRA BNP Paribas Easy - Equity.. 2.26 % 0.00 %

+0.54 (+0%)

USD 2.20M
MOEU:XETRA BNP Paribas Easy ESG Equi.. 2.26 % 0.00 %

+0.62 (+0%)

USD 2.20M
MOED:SW BNP Paribas Easy ESG Equi.. 2.26 % 0.00 %

N/A

USD 0.82M
MEM MAYBANK EMERGING ETF 1.88 % 0.00 %

-0.22 (0%)

USD 0.06B
SPY4:PA SSgA SPDR S&P 400 US Mid .. 0.61 % 0.00 %

+0.05 (+0%)

USD 2.97B
SPY4:XETRA SSgA SPDR S&P 400 US Mid .. 0.61 % 0.00 %

+0.38 (+0%)

USD 1.99B
SPY4:SW SPDR® S&P 400 US Mid Cap.. 0.61 % 0.00 %

-0.83 (0%)

USD 2.85B
ZMID:CA BMO S&P US Mid Cap Index .. 0.60 % 0.00 %

+0.04 (+0%)

N/A
IVOO Vanguard S&P Mid-Cap 400 .. 0.60 % 0.15 %

-0.55 (0%)

USD 2.43B
BRHY BlackRock High Yield ETF 0.08 % 0.00 %

+0.01 (+0%)

USD 0.10B
BSJO Invesco BulletShares 2024.. 0.00 % 0.42 %

N/A

N/A
MDY SPDR® S&P MIDCAP 400 ETF.. 0.00 % 0.24 %

-3.37 (0%)

USD 24.45B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

+0.06 (+0%)

USD 0.33B
PQIN 0.00 % 0.00 %

N/A

N/A
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
EXV6:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
ZMID-F:CA BMO S&P US Mid Cap Index .. 0.00 % 0.00 %

+0.16 (+0%)

CAD 2.03M
ZMID-U:CA BMO S&P US Mid Cap Index .. 0.00 % 0.00 %

N/A

N/A
CRIT Optica Rare Earths & Crit.. 0.00 % 0.00 %

-0.20 (0%)

USD 3.70M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.48% 37% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.48% 37% F 16% F
Trailing 12 Months  
Capital Gain 11.87% 58% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.87% 58% F 38% F
Trailing 5 Years  
Capital Gain 33.21% 63% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.21% 63% D 53% F
Average Annual (5 Year Horizon)  
Capital Gain 16.18% 79% B- 78% C+
Dividend Return 16.18% 74% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 47.95% 42% F 20% F
Risk Adjusted Return 33.74% 84% B 51% F
Market Capitalization 14.69B 71% C- 89% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector